Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bauss

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Zeitschrift Fur Orthopadie Und Ihre Grenzgebiete|May 23, 2000
[Anti-osteolytic therapy preserves trabecular structure and mechanical properties of bone in tumor osteolysis]A A Kurth, S Z Kim, F Bauss, et al.
Bone|February 14, 2003
Intermittent intravenous administration of the bisphosphonate ibandronate prevents bone loss and maintains bone strength and quality in ovariectomized cynomolgus monkeysS Y Smith, R R Recker, M Hannan, et al.
Bone|January 17, 2002
Ibandronate treatment decreases the effects of tumor-associated lesions on bone density and strength in the ratA A Kurth, S Z Kim, I Sedlmeyer, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 1, 1993
A new bisphosphonate, BM 21.0955, prevents bone loss associated with cessation of ovarian function in experimental dogsM C Monier-Faugere, R M Friedler, F Bauss, et al.
Bone|May 26, 1998
Effects of estrogen on the concentration of insulin-like growth factor-I in rat bone matrixJ Erdmann, S Storch, J Pfeilschifter, et al.
Calcified Tissue International|September 1, 1985
Comparative bone analysis via inflammation-mediated osteopenia (IMO) in the ratF Bauss, H W Minne, H Sterz, et al.
Zeitschrift Fur Orthopadie Und Ihre Grenzgebiete|December 29, 2005
[Improved osseointegration and periprosthetic bone volume around cementless metal implants under bisphosphonate treatment]C Eberhardt, W Raussen, S Thiemann, et al.
Bone|June 7, 2005
The bisphosphonate ibandronate improves implant integration in osteopenic ovariectomized ratsA H A Kurth, C Eberhardt, S Müller, et al.
European Urology|December 9, 2000
Impaired bone metabolism following augmentation cystoplasties in growing ratsD Brkovic, M Seibel, C Kissling, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 1, 1991
BM 21.0955, a potent new bisphosphonate to inhibit bone resorptionR C Mühlbauer, F Bauss, R Schenk, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Zeitschrift Fur Orthopadie Und Ihre Grenzgebiete|May 23, 2000
[Anti-osteolytic therapy preserves trabecular structure and mechanical properties of bone in tumor osteolysis]A A Kurth, S Z Kim, F Bauss, et al.
Bone|February 14, 2003
Intermittent intravenous administration of the bisphosphonate ibandronate prevents bone loss and maintains bone strength and quality in ovariectomized cynomolgus monkeysS Y Smith, R R Recker, M Hannan, et al.
Bone|January 17, 2002
Ibandronate treatment decreases the effects of tumor-associated lesions on bone density and strength in the ratA A Kurth, S Z Kim, I Sedlmeyer, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 1, 1993
A new bisphosphonate, BM 21.0955, prevents bone loss associated with cessation of ovarian function in experimental dogsM C Monier-Faugere, R M Friedler, F Bauss, et al.
Bone|May 26, 1998
Effects of estrogen on the concentration of insulin-like growth factor-I in rat bone matrixJ Erdmann, S Storch, J Pfeilschifter, et al.
Calcified Tissue International|September 1, 1985
Comparative bone analysis via inflammation-mediated osteopenia (IMO) in the ratF Bauss, H W Minne, H Sterz, et al.
Zeitschrift Fur Orthopadie Und Ihre Grenzgebiete|December 29, 2005
[Improved osseointegration and periprosthetic bone volume around cementless metal implants under bisphosphonate treatment]C Eberhardt, W Raussen, S Thiemann, et al.
Bone|June 7, 2005
The bisphosphonate ibandronate improves implant integration in osteopenic ovariectomized ratsA H A Kurth, C Eberhardt, S Müller, et al.
European Urology|December 9, 2000
Impaired bone metabolism following augmentation cystoplasties in growing ratsD Brkovic, M Seibel, C Kissling, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 1, 1991
BM 21.0955, a potent new bisphosphonate to inhibit bone resorptionR C Mühlbauer, F Bauss, R Schenk, et al.
Pageof 3